Heat shock protein 70-1 gene expression in pediatric heart surgery using blood cardioplegia

Background: In response to many stress stimuli, cardiomyocytes produce a common set of heat shock proteins (HSP). Up-regulation of HSP70-1 (the inducible isoform) is known to reduce the risk of myocardial cell damage during open-heart surgery and seems to be protective against ischemia. We assessed...

Full description

Saved in:
Bibliographic Details
Published inClinical chemistry and laboratory medicine Vol. 45; no. 2; pp. 244 - 248
Main Authors Vittorini, Simona, Storti, Simona, Andreani, Giovanna, Giusti, Lauro, Murzi, Bruno, Furfori, Pierantonio, Baroni, Alessandra, Lucia, Vittoria De, Luisi, Vincenzo Stefano, Clerico, Aldo
Format Journal Article
LanguageEnglish
Published Berlin Walter de Gruyter 01.02.2007
New York, NY
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: In response to many stress stimuli, cardiomyocytes produce a common set of heat shock proteins (HSP). Up-regulation of HSP70-1 (the inducible isoform) is known to reduce the risk of myocardial cell damage during open-heart surgery and seems to be protective against ischemia. We assessed hsp70-1 gene expression during blood cardioplegic arrest in children undergoing surgical correction of congenital heart defects. Methods: In tissue samples taken from the right atrium of 59 pediatric patients, we examined hsp70-1 gene expression using a real-time quantitative reverse transcription PCR, with 18S rRNA as internal standard. Results: On average, hsp70-1 gene expression was higher than the baseline level by a factor of 1.44± 0.17 (mean±SEM). A significant relationship between hsp70-1 mRNA levels and aortic cross-clamp time was observed (R2=0.069, p=0.044). Conversely, no significant correlation was observed between hsp70-1 mRNA levels and temperature. Conclusions: These data suggest that blood cardioplegia can induce an increment in the expression of hsp70-1, confirming its protective role in ischemia/reperfusion injury. Clin Chem Lab Med 2007;45:244–8.
Bibliography:cclm.2007.030.pdf
ark:/67375/QT4-TTZ12JRQ-G
istex:CA0BCA27C781ED9BD70A4BE47CDF85404647D11F
ArticleID:cclm.45.2.244
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1434-6621
1437-4331
DOI:10.1515/CCLM.2007.030